Detection of F8 mutations in carriers and patients with severe hemophilia A: Identification of a novel mutation
Invest. clín; 57 (4), 2016
The molecular diagnosis of haemophilia A (HA) patients has many benefits including diagnosis confirmation and inhibitor risk development prediction. In female carries of a mutation, the molecular diagnosis allows for genetic counseling and prenatal diagnosis, which have become part of the comprehensive c...